
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 971 | 971 | 932 | 1154 | 1837 | 1876 |
Fund Return | -2.92% | -2.92% | -6.83% | 4.9% | 12.93% | 6.5% |
Place in category | 121 | 121 | 124 | 11 | 3 | 45 |
% in Category | 65 | 65 | 68 | 6 | 1 | 42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Prudential Jennison Growth Z | 3.72B | -9.98 | 9.20 | 14.31 | ||
Prudential Jennison Global Opps Z | 2.68B | -11.07 | 3.58 | 12.03 | ||
Prudential Jennison Utility A | 2.6B | 1.90 | 6.44 | 8.35 | ||
Prudential Jennison Small Company Q | 1.78B | -8.21 | 0.69 | 8.26 | ||
Prudential Jennison Growth A | 1.73B | -10.04 | 8.88 | 13.97 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 34.63B | 0.63 | 2.20 | 6.39 | ||
T. Rowe Price Health Sciences | 6.8B | -0.04 | 0.26 | 7.27 | ||
Fidelity Select Health Care | 6.42B | -1.03 | 1.10 | 6.91 | ||
Vanguard Health Care Inv | 6.25B | 0.62 | 2.15 | 6.34 | ||
T. Rowe Price Health Sciences I | 4.79B | 0.00 | 0.39 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 15.09 | 754.36 | +3.00% | |
UnitedHealth | US91324P1021 | 4.76 | 586.93 | -2.09% | |
Vertex | US92532F1003 | 4.45 | 495.83 | +2.40% | |
Abbott Labs | US0028241000 | 4.44 | 127.96 | +0.85% | |
argenx ADR | US04016X1019 | 4.37 | 607.52 | +4.58% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review